Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients a review

The Centers for Medicare & Medicaid Services (CMS) requested that AHRQ commission an evidence report to inform CMS of the evidence regarding ultrasound-based monitoring of cardiac output (Doppler). This is currently listed as a Category II procedure (clinical reliability and efficacy not proven)...

Full description

Bibliographic Details
Corporate Author: United States Agency for Healthcare Research and Quality
Format: eBook
Language:English
Published: Rockville, Maryland Agency for Healthcare Research and Quality January 16, 2007, 2007
Series:Technology assessment
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01681nam a2200277 u 4500
001 EB002010923
003 EBX01000000000000001173822
005 00000000000000.0
007 tu|||||||||||||||||||||
008 220201 r ||| eng
245 0 0 |a Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients  |h Elektronische Ressource  |b a review 
260 |a Rockville, Maryland  |b Agency for Healthcare Research and Quality  |c January 16, 2007, 2007 
300 |a 1 PDF file (ix, 120)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Monitoring, Physiologic 
653 |a Echocardiography, Transesophageal 
653 |a Cardiac Output 
653 |a Ultrasonography, Doppler 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Technology assessment 
500 |a Title from PDF title page 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK258763  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The Centers for Medicare & Medicaid Services (CMS) requested that AHRQ commission an evidence report to inform CMS of the evidence regarding ultrasound-based monitoring of cardiac output (Doppler). This is currently listed as a Category II procedure (clinical reliability and efficacy not proven), which is "considered experimental and should not be covered at this time". Accordingly, on May 9th 2006, AHRQ, in consultation with CMS and ECRI, issued a Statement of Work (SOW) contracting ECRI to prepare an evidence report on this topic